Iovance Biotherapeutics Signs New Headquarters Lease and Terminates Previous Lease Agreement
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a Delaware-based biotechnology company, has recently announced significant changes in its office locations and lease agreements. On November 15, 2024, the company finalized a sublease agreement with Vaxcyte, Inc. for Suite 100 at 825 Industrial Road, San Carlos, California. This move comes as part of the company’s strategic initiatives to […]
More Stories
Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a report published on Monday morning....
Reading International (NASDAQ:RDI) Now Covered by StockNews.com
StockNews.com began coverage on shares of Reading International (NASDAQ:RDI – Free Report) in a report issued on Monday. The firm...
Symbolic Logic (NASDAQ:EVOL) Now Covered by StockNews.com
StockNews.com started coverage on shares of Symbolic Logic (NASDAQ:EVOL – Free Report) in a research report sent to investors on...
Remark (NASDAQ:MARK) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Remark (NASDAQ:MARK – Free Report) in a research report released on Monday. The firm...
StockNews.com Downgrades Lithia Motors (NYSE:LAD) to Sell
Lithia Motors (NYSE:LAD – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in...
iShares MSCI United Kingdom Small-Cap ETF (BATS:EWUS) Trading 0.4% Higher – Time to Buy?
iShares MSCI United Kingdom Small-Cap ETF (BATS:EWUS – Get Free Report) shares traded up 0.4% during mid-day trading on Thursday...